Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S2 pseudogene 5 (RPS2P5) is a processed pseudogene derived from the RPS2 gene, which encodes a component of the small (40S) ribosomal subunit[5]. Pseudogenes like RPS2P5 are genomic DNA sequences that arise from protein-coding genes but have lost their coding potential due to disabling mutations, truncations, or lack regulatory elements required for expression[2][5]. While most processed pseudogenes are nonfunctional and not transcribed or translated, some may occasionally contribute to genomic evolution or gene regulation, but there is no evidence that RPS2P5 produces a functional product or is involved in therapeutic contexts[2][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S2 pseudogene 5 (RPS2P5).